Compositions and methods for treating surgical adhesions

Overview

Information

Number
6689803
Application
10/067467
Filing date
02/05/2002
Issue date
02/10/2004
Inventor(s)
William L. Hunter
US Classification
514/365
View at USPTO

Citations

Sanofi-aventis (10)
ALABAMA AT BIRMINGHAM, UNIVERSITY OF (5)
Bristol-Myers Squibb (5)
Angiotech International (4)
IPXMEDICAL, LLC (4)
Poly-Med (4)
NA (3)
Merrell Dow Pharmaceuticals (3)
Regents of the University of California, The (3)
Thomas Jefferson University (2)
The United States of America as represented by the Department of Health (2)
Children's Medical Center (2)
Pfizer (2)
The Johns Hopkins University (2)
Massachusetts Institute Of Technology (2)
Eisai Co. (2)
UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (2)
COOK MEDICAL TECHNOLOGIES (1)
Matrix Pharmaceutical (1)
SPEED GEL (1)
HOSTETLER FAMILY TRUST (1)
Vertex Pharmaceuticals (1)
Rhone-Poulenc Rorer (1)
Phanos Technologies (1)
HOSTETLER, KARL Y. (1)
Regents Of The University of Minnesota (1)
Montana State University (1)
Advanced cardiovascular Systems (1)
ANGIODEVICE INTERNATIONAL (1)
Procter & Gamble (1)
McGill University (1)
Chemex Pharmaceuticals (1)
PG-TXL (1)
Celgene (1)
Tapestry Pharmaceuticals (1)
COVALON technology (1)
Hospira (1)
Chimerix (1)
Vestar (1)
AMO UPPSALA AB (1)

Abstract

Abstract

Methods and compositions for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis are provided, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Assignees with Similar Patents

Angiotech International (19)
PG-TXL (12)
IPXMEDICAL, LLC (8)
ANGIODEVICE INTERNATIONAL (5)
Samyang (5)

Referenced by

Boston Scientific (38)
conextions (19)
CritiTech (17)
broncus medical (16)
Celgene (12)
dfb soria (7)
University of Utah (5)
SurModics (4)
resurge therapeutics (4)
Cardiac Pacemakers (2)
ROCHE DIAGNOSTICS HEMATOLOGY, INC. (2)
COOK MEDICAL TECHNOLOGIES (2)
Covidien (2)
Broncus Technologies (2)
Industrial Technology research Institute (2)
SWEET, RICHARD M. (2)
Otago Innovation (1)
UNIVERSITY OF BRITISH COLUMBIA, THE (1)
Remon Medical Technologies (1)
University of Kentucky Research Foundation (1)
Bristol-Myers Squibb (1)
critltech (1)
Omeros (1)
Abbott Laboratories (1)
dfb soria ll (1)

Tech Analysis

Class Subclass Type Reference Factor Citation Factor Strength Grant time Early grant (%)
514 365 Emerging Sustaining Seminal Medium Average 40.7